No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Phase I Clinical Trial Results for Intas’ Denosumab Biosimilar Accepted by CDSCO
As reported by Medical Dialogues, India’s Central Drugs Control Organisation (CDSCO) has reviewed and accepted without objection a final Clinical Study Report (CSR) submitted by Intas